Sunday 22 October 2017

CorkHi13°| Lo

Cork Independent

News

Spotlight on pre-eclampsia

Wednesday, 11th October, 2017 4:58pm

A world-leading research centre at UCC and CUH is to undertake a comprehensive study of 4,000 women aimed at improving the outcomes of pregnant women with suspected pre-eclampsia.

The Irish Centre for Fetal and Neonatal Translational Research (INFANT) is Ireland’s first dedicated perinatal research centre.

In collaboration with the Health Research Board (HRB) Mother & Baby Network, the research will investigate a point-of-care diagnostic platform that will measure the potential benefits of offering an additional blood test to measure placental growth factor (PlGF) to improve the outcomes for both mother and baby when pre-term pre-eclampsia (PET) is suspected.

Pre-eclampsia is a pregnancy complication that can affect any woman and there is no treatment for it.

The HRB Mother and Baby Clinical Trial Network Ireland brings together leading Irish obstetric and neonatal researchers, with an international reputation to address problems in women and children’s health that will have a global impact.

The PARROT Ireland research programme aims to more effectively diagnose pregnant women when it is suspected they may have PET so that their care may be managed more efficiently. Professor Louise Kenny, co-director of INFANT, said: “This study is a unique opportunity to make immediate changes to a patient suspected of having pre-eclampsia’s care using a point-of-care device.

“Results of the test are available within 30 minutes, ensuring information is relayed to the treating clinician in a timely manner.

“This study will combine the wide range of expertise in the INFANT centre and the HRB Mother & Baby Network and contribute to a more stratified system of patient management which in turn will lead to better outcomes for mother and baby,” she said.

Diagnosing mothers earlier would have an impact on their medical outcomes and also upon hospital resources, reducing unnecessary admissions.

The PARROT Ireland programme is a follow on to the PELICAN study. INFANT took part in this multicentre prospective study to evaluate the use of PlGF tests in women presenting with suspected PET.

The study suggests that PlGF testing presents a realistic and innovative adjunct to the management of women with suspected PET, especially in those presenting preterm.

This all-island study will invite 4,000 pregnant women over two years in seven centres around Ireland – CUMH, the National Maternity Hospital, Coombe Women and Infants University Hospital, the Rotunda Maternity Hospital, University Hospital Galway, University Maternity Hospital Limerick and the Royal Jubilee Maternity Service Hospital in Belfast.

ePaper Service

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8
Desktop, Tablet & Smartphone friendly
Contributors

Title: Deputy Editor/News Editor

@bhayescurtin

Title: Journalist/Sub Editor

@louisecashell

Title: Journalist

Title: Style Columnist

Title: GAA Columnist

Title: Beauty columnist

Title: Columnist, Our City Our Town

Title: Columnist, Food

Title: Motoring correspondent

@neilmbriscoe

Title: Intern Journalist

Cookies on Cork Independent website
We use cookies to ensure that we give you the best experience on our website. We also use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the Cork Independent website. However, if you would like to, you can change your cookie settings at any time by amending your browser settings.
How does Cork Independent use cookies?
Cookies enable us to identify your device, or you when you have logged in. We use cookies that are strictly necessary to enable you to move around the site or to provide certain basic features. We use cookies to enhance the functionality of the website by storing your preferences, for example. We also use cookies to help us to improve the performance of our website to provide you with a better user experience.
We don't sell the information collected by cookies, nor do we disclose the information to third parties, except where required by law (for example to government bodies and law enforcement agencies).
Hide Message